Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study

MLA

Jason, Akulian, et al. “Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study.” Chest, vol. 162, no. 6, Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........a6d927541d957ce4300a22a971b7f345&authtype=sso&custid=ns315887.

APA

Jason, A., Eihab O, B., Hawazin, A., Christine, A., David T, A., Akshu, B., Hitesh, B., Juan Pablo, U. B., Adam, B., Kristin, B., Allen Cole, B., Jiwoon, C., Ara A, C., David M, D., Xavier Fonseca, F., Yaron B, G., Christopher R, G., Kristen, G., Mark, G., … Lonny, Y. (2022). Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study. Chest, 162(6).

Chicago

Jason, Akulian, Bedawi Eihab O, Abbas Hawazin, Argento Christine, Arnold David T, Balwan Akshu, Batra Hitesh, et al. 2022. “Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study.” Chest 162 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........a6d927541d957ce4300a22a971b7f345&authtype=sso&custid=ns315887.